Evidence map›Paper›PMID 26084027›Full record

ArticleImmunity2015

Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity.

Paul M Gallo, Glenn J Rapsinski, R Paul Wilson, Gertrude O Oppong, Uma Sriram, Mark Goulian, Bettina Buttaro, Roberto Caricchio, Stefania Gallucci, Çagla Tükel

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 221 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Biofilm-associated molecular patterns: BAMPs.Infection and immunity · 2025
    Review
  16. The Evolution of Functional Amyloids and Their Impact on Host-Microbe Interactions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  17. Increased Susceptibility toLife (Basel, Switzerland) · 2025
    Article
  18. Review
  19. Review
  20. Review

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Paul M GalloDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA; Laboratory of Dendritic Cell Biology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
Glenn J RapsinskiDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
R Paul WilsonDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
Gertrude O OppongDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
Uma SriramDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA; Laboratory of Dendritic Cell Biology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
Mark GoulianDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Bettina ButtaroDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
Roberto CaricchioDivision of Rheumatology, Department of Medicine, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
Stefania GallucciDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA; Laboratory of Dendritic Cell Biology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
Çagla TükelDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA. Electronic address: ctukel@temple.edu.
Temple University · USUniversity of Pennsylvania · US

Funding

Regulation of Bacterial Two-Component Signaling by Small Membrane ProteinsR01GM080279 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI GOULIAN, MARK D · 2007 to 2020
$3.7M
The role of cell death in Lupus NephritisR01AR061569 · NIAMS · TEMPLE UNIV OF THE COMMONWEALTH · PI CARICCHIO, ROBERTO · 2012 to 2016
$2.3M
Regulation of Type I IFNs in Tolerance and AutoimmunityR01AI076423 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GALLUCCI, STEFANIA · 2009 to 2013
$1.7M
The role of curli fibrils in modulating immune responses in the gutR21AI105370 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI TUKEL, CAGLA · 2014 to 2015
$428k
Regulation of intestinal barrier by E. coli curli fibrilsR03AI107434 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI TUKEL, CAGLA · 2013 to 2014
$151k
NIAID NIH HHS 1R03AI107434NIAID NIH HHS 1R21AI105370NIAID NIH HHS R01 AI076423NIAID NIH HHS R01-AI076423NIAID NIH HHS R03 AI107434NIAID NIH HHS R21 AI105370NIAMS NIH HHS R01 AR061569NIAMS NIH HHS R01-AR061569NIGMS NIH HHS R01 GM080279
6 · The paper itself

Abstract

Research on the human microbiome has established that commensal and pathogenic bacteria can influence obesity, cancer, and autoimmunity through mechanisms mostly unknown. We found that a component of bacterial biofilms, the amyloid protein curli, irreversibly formed fibers with bacterial DNA during biofilm formation. This interaction accelerated amyloid polymerization and created potent immunogenic complexes that activated immune cells, including dendritic cells, to produce cytokines such as type I interferons, which are pathogenic in systemic lupus erythematosus (SLE). When given systemically, curli-DNA composites triggered immune activation and production of autoantibodies in lupus-prone and wild-type mice. We also found that the infection of lupus-prone mice with curli-producing bacteria triggered higher autoantibody titers compared to curli-deficient bacteria. These data provide a mechanism by which the microbiome and biofilm-producing enteric infections may contribute to the progression of SLE and point to a potential molecular target for treatment of autoimmunity.

Indexed as

AmyloidAnimalsAutoantibodiesBacterial ProteinsBiofilmsCells, CulturedDendritic CellsDNA, BacterialEscherichia coliEscherichia coli InfectionsHumansInterferon Type ILupus Erythematosus, SystemicMiceMice, 129 StrainMice, Inbred C57BLAmyloidAutoantibodiesBacterial ProteinsDNA, BacterialInterferon Type I

Identifiers

PMID26084027
PMCPMC4500125
OpenAlexW1546703330

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.